WeeCare ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  12.5% 8.3% 13.1% 19.5% 23.3%  
Credit score (0-100)  20 30 16 6 3  
Credit rating  BB BB BB B B  
Credit limit (kDKK)  -0.0 -0.0 -0.0 -0.0 -0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  60.7 273 254 136 20.5  
EBITDA  -130 -137 -63.2 -61.8 -128  
EBIT  -130 -137 -63.2 -61.8 -128  
Pre-tax profit (PTP)  -130.7 -169.5 -95.7 -99.9 -190.6  
Net earnings  -102.3 -133.9 -74.8 -184.8 -190.6  
Pre-tax profit without non-rec. items  -131 -170 -95.7 -99.9 -191  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  -101 -235 -271 -456 -646  
Interest-bearing liabilities  513 647 0.0 0.0 0.0  
Balance sheet total (assets)  471 494 630 486 331  

Net Debt  489 614 -30.8 -133 -34.9  
 
See the entire balance sheet

Volume 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  60.7 273 254 136 20.5  
Gross profit growth  0.0% 349.5% -7.0% -46.6% -84.9%  
Employees  2 2 2 1 1  
Employee growth %  0.0% 0.0% 0.0% -50.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  471 494 630 486 331  
Balance sheet change%  0.0% 4.8% 27.6% -22.9% -31.8%  
Added value  -129.9 -137.1 -63.2 -61.8 -128.4  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 0 0  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  -1.0 -2.0 -3.0 -4.0 -5.0  

Profitability 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  -214.0% -50.2% -24.9% -45.6% -627.3%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  -22.7% -21.1% -7.8% -6.7% -13.4%  
ROI %  -25.3% -23.6% -19.6% 0.0% 0.0%  
ROE %  -21.7% -27.7% -13.3% -33.1% -46.7%  

Solidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  -17.7% -32.3% -30.1% -48.4% -66.1%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -376.5% -448.0% 48.7% 215.5% 27.2%  
Gearing %  -506.6% -275.0% 0.0% 0.0% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  0.3% 5.6% 10.0% 0.0% 0.0%  

Liquidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  0.3 0.2 0.2 0.2 0.1  
Current Ratio  0.8 0.7 0.7 0.5 0.3  
Cash and cash equivalent  24.1 32.7 30.8 133.3 34.9  

Capital use efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  -101.3 -235.2 -271.0 -455.8 -646.5  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  -65 -69 -32 -62 -128  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  -65 -69 -32 -62 -128  
EBIT / employee  -65 -69 -32 -62 -128  
Net earnings / employee  -51 -67 -37 -185 -191